Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Dan Jeffries has, and his insightful and entertaining talk explores what it's like living with one of the world's rarest
medical conditions - and then finding out you have another one. Dan was diagnosed with Wyburn-Mason
syndrome at four-years old. It is an exceptionally rare AVM (Artereovemous Malformation), situated around the
midbrain and optic nerve. As a consequence, Dan is blind in his left eye. The AVM is untreatable and there are
thought to be less than 100 reported cases in the past fifty years — worldwide. That works out to be about 1 in 70
million people. Pretty rare. And then, as he turned 30, Dan discovered that he had Acromegaly — a benign tumor
in the pituitary gland. About 6 people per million are diagnosed with this unique and challenging condition that
effects growth homrone and IGF-1 production, as well as impacting on vision, facial appearance, hands and feet,
teeth, libido and more. Being Rare explores the early days of diagnosis, living with Wyburn-Mason syndrome and
how things started to change during his twenties, leading to the bizarre discovery of Acromegaly — discovered by
student doctors. Using an innovative slideshow, Dan is able to show key images, doctors notes and more, reflecting
the methods used to tell his story in his published memoir, Me, Myself & Eye. Dan also explores the impact of living
with rare conditions and how this can affect the individual on a day-to-day basis, as well as the empowerment it can
bring too. “Dan’s talk managed to be informative and entertaining, insightful and moving, educational and inspiring.
You don’t often find presentations that manage to combine all of those qualities! I left with a deeper understanding
of what it is like to live with rare conditions, and also with a smile on my face!” - Pfizer UK.